Inducing properties of rifampicin and rifabutin for selected enzyme activities of the cytochrome P-450 and UDP-glucuronosyltransferase superfamilies in female rat liver

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 6, 1996, Pages 1111-1119

  Oesch, F ^a   Arand, M ^a   Strolin Benedetti, M ^b   Castelli, M G ^b   Dostert, P ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Pharmacia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; GLUCURONOSYLTRANSFERASE; RIFABUTIN; RIFAMPICIN; TESTOSTERONE; TUBERCULOSTATIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; GLUCURONIDATION; GUINEA PIG; HUMAN; HYDROXYLATION; LIVER; LIVER MICROSOME; MOUSE; NONHUMAN; RABBIT; RAT; SPECIES DIFFERENCE;

ANIMALS; ANTIBIOTICS, ANTITUBERCULAR; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCURONOSYLTRANSFERASE; LIVER; RATS; RATS, WISTAR; RIFABUTIN; RIFAMPIN; TESTOSTERONE;

EID: 0029758162     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.6.1111     Document Type: Article

References (28)

1. Acocella, G., Pagani, V., Marchetti, M., Baroni, G. C. & Nicolis, F. B. (1971). Kinetic studies on rifampicin. I. Serum concentration analysis in subjects treated with different oral doses over a period of two weeks. Chemotherapy 16, 356-70.
2. Adachi, Y., Nanno, T., Yamashita, M., Ueshima, S. & Yamamoto, T. (1985). Induction of rat liver bilirubin-conjugating enzymes and glutathione S-transferase by rifampicin. Gastroenterologia Japonica 20, 104-10.
3. Barone, D., Beretta, E. & Tenconi, L. T. (1972). Rifampicin and liver drug-metabolizing systems. Studies in guinea-pigs, rats and mice. Acta Vitaminologica et Enzymologica 26, 124-5.
4. Bock, K. W., Josting, D., Lilienblum, W. & Pfeil, H. (1979). Purification of rat-liver microsomal UDP-glucuronyltransferase. Separation of two enzyme forms inducible by 3-methylcholanthrene or phenobarbital. European Journal of Biochemistry 98, 19-26.
5. Bock, K. W. & White, I. N. H. (1974). UDP-glucuronyltransferase in perfused rat liver and in microsomes: influence of phenobarbital and 3-methylcholanthrene. European Journal of Biochemistry 46, 451-9.
6. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Analytical Biochemistry 72, 248-54.
7. Brughera, M., Scampini, G., Newman, A. J., Castellino, S., Sammartini, U. & Mazué, G. (1995). Overview of toxicological data on rifabutin. Experimental and Toxicologic Pathology 47, 1-9.
8. Burke, M. D. & Mayer, R. T. (1974). Ethoxyresorufin. Direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metabolism and Disposition 2, 583-8.
9. Burke, M. D. & Mayer, R. T. (1976). Inherent specificities of purified cytochromes P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation. Drug Metabolism and Disposition 3, 245-53.
10. Cameron, W., Sparti, P., Pietroski, N., Pearce, D., Eron, L., Sullam, P. et al. (1992). Rifabutin therapy for the prevention of Mycobacterium avium complex (MAC) bacteremia in patients with AIDS and CD4 ≤200. In Program and Abstracts of the VIII International Conference on AIDS and the III STD World Congress, Harvard-Amsterdam Conference, Amsterdam, 1992. Abstract WeB 1055, p. We54.
11. Daujat, M., Pichard, L., Fabre, I., Pineau, T., Fabre, G., Bonfils, C. et al. (1991). Induction protocols for cytochromes P450IIIA in vivo and in primary cultures of animal and human hepatocytes. In Methods in Enzymology-Cytochrome P450, Vol. 206 (Waterman, M. R. & Johnson, E. F., Eds), pp. 345-53. Academic Press, New York.
12. De Cian, W., Sassella, D. & Wynne, B. A. (1996). Clinical experience with rifabutin in the treatment of mycobacterial infections. Scandinavian Journal of Infectious Diseases, Suppl. in press.
13. Della Bruna, C., Schioppacassi, G., Ungheri, D., Jabès, D., Morvillo, E. & Sanfilippo, A. (1983). LM 427, a new spiropiperidylrifamycin: in vitro and in vivo studies. Journal of Antibiotics 36, 1502-6.
14. Fleming, C. M., Branch, R. A., Wilkinson, G. R. & Guengerich, F. P. (1992). Human liver microsomal N-hydroxylation of dapsone by cytochrome P4503A4. Molecular Pharmacology 41, 975-80.
15. Ged, C., Rouillon, J. M., Pichard, L., Combalbert, J., Bressot, N., Bories, P. et al. (1989). The increase in urinary excretion of 6β-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. British Journal of Clinical Pharmacology 28, 373-87.
16. Gonzalez, F. J. (1992). Human cytochromes P450: problems and prospects. Trends in Pharmacological Sciences 13, 346-52.
17. Grosset, J. H. (1988). New approaches in antimycobacterial chemotherapy. Drugs Today 24, 291-301.
18. Lubet, R. A., Syi, J. L., Nelson, J. O. & Nims, R. W. (1990). Induction of hepatic cytochrome P-450 mediated alkoxyresorufin O-dealkylase activities in different species by prototype P-450 inducers. Chemico-Biological Interactions 75, 325-39.
19. Murray, M. (1992). P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease. Clinical Pharmacokinetics 23, 132-46.
20. Namkung, M. J., Yang, H. L., Hulla, J. E. & Juchau, M. R. (1988). On the substrate specificity of cytochrome P450IIIA1. Molecular Pharmacology 34, 628-37.
21. Oesch, F. Wagner, H., Platt, K. L. & Arand, M. (1992). Improved sample preparation for the testosterone hydroxylation assay using disposable extraction columns. Journal of Chromatography 582, 232-5.
22. Perucca, E., Grimaldi, R., Frigo, G. M., Sardi, A., Mönig, H. & Ohnhaus, E. E. (1988). Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects. European Journal of Clinical Pharmacology 34, 595-9.
23. Rao, G. S., Haueter, G., Rao, M. L. & Breuer, H. (1976). An improved assay for steroid glucuronyltransferase in rat liver microsomes. Analytical Biochemistry 74, 35-40.
24. Scampini, G., Nava, A., Newman, A. J., Della Torre, P. & Mazué, G. (1993). Multinucleated hepatocytes induced by rifabutin in rats. Toxicologic Pathology 21, 369-76.
25. Sparti, P., Pietroski, N., Pearce, D., Eron, L., Sullam, P., Conant, M. et al. (1992). Rifabutin prevents Mycobacterium avium complex (MAC) bacteremia in patients with AIDS and CD4 ≤200. In Program and Abstracts of the Thirty-Second Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, California, 1992. Abstract 888, p. 258.
26. Spjotvol, E. & Stoline, M. R. (1973). An extension of the t-method of multiple comparison to include the cases with unequal sample sizes. Journal of American Statistical Association 68, 975-8.
27. Strolin Benedetti, M. & Dostert, P. (1994). Induction and autoinduction properties of rifamycin derivatives. Environmental Health Perspectives 102, Suppl. 9, 101-5.
28. Strolin Benedetti, M., Duchene, P. & Olliaro, P. (1991). Investigation on a possible induction of AZT glucuronidation by rifabutin and rifampicin in humans. In Program and Abstracts of the Third International ISSX Meeting, Amsterdam, 1991. Abstracts 295.